Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Dermatologic 1

Conditions

Skin Neoplasms 1Pancreatic Neoplasms 1Esophageal Neoplasms 1Cicatrix 1

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
abobotulinumtoxinA × Clear all
NCT04965311 2025-05-13

Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy

OHSU Knight Cancer Institute

Phase 2 Terminated
4 enrolled 9 charts
Gastrointestinal

Pancreatic Neoplasms

NCT02965976 2023-02-16

Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer

Roswell Park Cancer Institute

Phase 2 Completed
33 enrolled 17 charts
Gastrointestinal

Esophageal Neoplasms

NCT01459666 2022-05-26

Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer

University Hospitals Cleveland Medical Center

Phase 4 Terminated
9 enrolled 6 charts
Dermatologic

Cicatrix, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡